Liebers, N., Duell, J., Fitzgerald, D., Kerkhoff, A., Noerenberg, D., Kaebisch, E., . . . Dietrich, S. (2021). Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood Adv.
Chicago Style aipamenaLiebers, Nora, et al. "Polatuzumab Vedotin As a Salvage and Bridging Treatment in Relapsed or Refractory Large B-cell Lymphomas." Blood Adv 2021.
MLA aipamenaLiebers, Nora, et al. "Polatuzumab Vedotin As a Salvage and Bridging Treatment in Relapsed or Refractory Large B-cell Lymphomas." Blood Adv 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.